Going Anti-Viral
Tufts researchers and clinicians are teaming up to stop the spread of HPV—and prevent the cancers it causes.
Public Health and Community Medicine
One Center’s Oversized Impact on Drug Development and Clinical Trials
Tufts Center for the Study of Drug Development celebrates 50 years of research and data publication to inform improvements in pharmaceutical development and regulatory policy.
What Is Cyclosporiasis and Why Are Cases on the Rise?
Infectious disease specialists at Tufts share what they know about a parasite that has made thousands of people sick this summer.
Connecting Classrooms, Clinics, and Continents
An international fellowship united two physician-scientists in their quest to improve global health.
Experts Describe Myriad Challenges in Fight to Control Ebola Outbreak
Infectious disease researchers share what it will take to stop the spread of the disease in the Democratic Republic of the Congo.
New Frontiers in Brain and Behavior
From early detection to clinical application, Tufts’ Neurosciences and Behavioral Health Research Day showcases new discoveries and advances strategies for translating innovation into better patient outcomes.
Why Are Medications Administered in Different Forms?
A Tufts expert explains the factors associated with determining the best method of delivery of pharmaceutical drugs.
A World Without TB? John Green Says It’s Overdue
In a talk at Tufts, the author takes on the deadly disease and the fault in our values that helps it persist.
Family Dinners May Reduce Substance-Use Risk for Many Adolescents
Regular bonding over meals may help prevent kids from using alcohol, cannabis, and e-cigarettes, but those with significant stress or trauma need additional support.